Citadel Advisors’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $795K | Buy |
|
|||||
|
2025
Q2 | $47.7K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $427K | Buy |
|
|||||
|
2024
Q3 | $292K | Buy |
|
|||||
|
2024
Q2 | $31.7K | Sell |
|
|||||
|
2024
Q1 | $181K | Sell |
|
|||||
|
2023
Q4 | $238K | Sell |
|
|||||
|
2023
Q3 | $1.94M | Buy |
|
|||||
|
2023
Q2 | $1.3M | Sell |
|
|||||
|
2023
Q1 | $1.87M | Sell |
|
|||||
|
2022
Q4 | $4.94M | Sell |
|
|||||
|
2022
Q3 | $8.89M | Sell |
|
|||||
|
2022
Q2 | $9.25M | Sell |
|
|||||
|
2022
Q1 | $11M | Buy |
|
|||||
|
2021
Q4 | $1.15M | Buy |
|
|||||
|
2021
Q3 | $423K | Buy |
|
|||||
|
2021
Q2 | $318K | Sell |
|
|||||
|
2021
Q1 | $3.06M | Sell |
|
|||||
|
2020
Q4 | $9.09M | Buy |
|
|||||
|
2020
Q3 | $7.62M | Buy |
|
|||||
|
2020
Q2 | $223K | Buy |
|
|||||
|
2020
Q1 | $95K | Buy |
|
|||||
|
2019
Q4 | $171K | Buy |
|
|||||
|
2019
Q3 | $91K | Buy |
|
|||||
|
2019
Q2 | $68K | Sell |
|
|||||
|
2019
Q1 | $297K | Buy |
|
|||||
|
2018
Q4 | $107K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $91K | Buy |
|
|||||
|
2018
Q1 | $84K | Buy |
|